CI-135 CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CI-135 CAR-T Cells, covering 2024-11-14 to 2024-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects with Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]